Nano-Bio
Intersection of biology and nanotechnology
NanoString Technologies
Seattle, United States
Life sciences company developing tools for gene expression analysis using nanoparticle-based molecular barcoding technology
Arrowhead Research
Pasadena, United States
Biopharmaceutical company developing targeted RNAi therapeutics using proprietary TRiM platform
BIND Therapeutics
Cambridge, United States
BIND Therapeutics, founded in 2007 and based in Cambridge, Massachusetts, pioneered the Accurin platform of polymeric nanoparticles for targeted cancer drug delivery, representing one of the most advanced clinical applications of nanomedicine. With over $150 million in funding and 100-200 employees, BIND developed sophisticated nanotechnology designed to precisely deliver chemotherapy agents to tumor cells while minimizing systemic toxicity. The company emerged from groundbreaking research at MIT and Harvard on controlled drug delivery using biodegradable polymer nanoparticles. BIND's Accurin nanoparticles were engineered with extraordinary precision, incorporating multiple functional components: a biodegradable polymer core loaded with chemotherapy drugs, a protective hydrophilic polymer shell to evade immune system clearance, and targeting ligands that bind to specific molecules overexpressed on cancer cells. This multicomponent design addressed fundamental challenges in cancer treatment—delivering sufficient drug to tumors while avoiding damage to healthy tissues. The company's lead candidate, BIND-014, consisted of docetaxel chemotherapy encapsulated in nanoparticles displaying PSMA-targeting ligands, designed for prostate cancer treatment. BIND advanced multiple nanoparticle candidates through clinical trials, generating valuable data on nanomedicine performance in humans. The company's clinical programs demonstrated that carefully designed nanoparticles could alter drug biodistribution, enhance tumor accumulation, and potentially improve therapeutic indices. BIND employed sophisticated polymer chemistry and formulation sciences to create nanoparticles with controlled sizes (typically 50-100 nanometers), precise drug loading, and sustained release profiles. The company developed scalable manufacturing processes meeting pharmaceutical GMP standards—a significant achievement given the complexity of multi-functional nanoparticles. Throughout its existence, BIND contributed substantially to understanding how nanoparticle properties including size, surface chemistry, and targeting ligands influence biological fate and therapeutic efficacy. Despite promising preclinical data and successful clinical trial execution, BIND faced challenges common to nanomedicine development including complex regulatory pathways, high development costs, and difficulty demonstrating sufficient therapeutic advantages over existing treatments. In 2016, facing financial pressures, BIND was acquired by Pfizer, which subsequently discontinued the programs, highlighting the challenging economics of nanomedicine development. Nevertheless, BIND's legacy includes important contributions to nanomedicine science, demonstration that sophisticated nanoparticles can be manufactured at pharmaceutical scales, and clinical data advancing understanding of nanoparticle behavior in humans. The company's experience provides valuable lessons for the nanomedicine field regarding the gap between preclinical promise and clinical reality, the importance of selecting appropriate patient populations, and the need for compelling therapeutic differentiation to justify nanomedicine's inherent complexity.
Nanofiber Solutions
Columbus, United States
Developer of 3D nanofiber scaffolds for tissue engineering and cell culture applications
Fibenamics
Guimaraes, Portugal
Specialized in electrospun nanofiber production for healthcare and industrial applications
NanoViricides
Shelton, United States
Developer of nanoviricide drugs designed to attack and destroy viruses
Nanobio Corporation
Ann Arbor, United States
Developer of nanoemulsion-based products for infection and vaccine delivery
Tarveda Therapeutics
Watertown, United States
Developer of miniature drug conjugates for targeted cancer therapy
National Nanotechnology Initiative
Washington, United States
US government R&D initiative coordinating nanotechnology research across federal agencies
Nanyang Technological University - CNRS
Singapore, Singapore
International joint laboratory for nanotechnology and materials science research
MIT.nano
Cambridge, United States
MIT's open-access facility for nanoscale research and fabrication
Harris & Harris Group
New York, United States
Venture capital firm focused on nanotechnology and transformative companies
Lux Capital
New York, United States
Venture capital firm investing in deep technology including nanotechnology
Nanosonics
Sydney, Australia
Global leader in infection prevention with proprietary nanotechnology-based disinfection systems for medical devices
Moderna
Cambridge, United States
Pioneer in mRNA therapeutics using lipid nanoparticle (LNP) delivery technology for vaccines and medicines
Acuitas Therapeutics
Vancouver, Canada
Leading developer of lipid nanoparticle (LNP) delivery systems for nucleic acid therapeutics, partner for COVID-19 vaccines
Alnylam Pharmaceuticals
Cambridge, United States
Pioneer in RNAi therapeutics using lipid nanoparticle delivery for treatment of genetic diseases
Intellia Therapeutics
Cambridge, United States
Gene editing company using lipid nanoparticle delivery for in vivo CRISPR therapeutics
Codiak BioSciences
Cambridge, United States
Codiak BioSciences, founded in 2015 in Cambridge, Massachusetts, is a pioneering biotechnology company at the forefront of exosome-based therapeutics. The company has developed the proprietary engEx platform, which engineers exosomes—naturally occurring nanovesicles (30-150 nanometers) secreted by cells—as sophisticated drug delivery vehicles. Unlike synthetic nanoparticles, exosomes offer inherent biocompatibility, low immunogenicity, and natural ability to cross biological barriers, making them ideal carriers for therapeutic payloads. Codiak's engEx technology precisely modifies exosomes to display specific targeting molecules on their surface while loading therapeutic cargo inside, creating programmable nanomedicines with enhanced tissue specificity and therapeutic efficacy. The company's lead programs include exoSTING, an exosome-delivered STING agonist for cancer immunotherapy, and exoIL-12, which delivers interleukin-12 for tumor treatment. These engineered exosomes leverage the body's natural intercellular communication system to deliver potent immunomodulatory agents directly to target cells, potentially revolutionizing cancer treatment with improved safety profiles compared to conventional delivery methods. Codiak has raised over $300 million in funding, reflecting significant investor confidence in exosome therapeutics. The Cambridge location places Codiak at the heart of the biotech innovation ecosystem, with access to world-renowned research institutions and clinical infrastructure. The company employs between 100-200 specialists in molecular biology, nanotechnology, and clinical development. Exosomes represent a convergence of cell biology and nanotechnology, and Codiak's platform addresses critical challenges in drug delivery including tumor penetration, immune evasion, and payload stability. As the field of nanomedicine evolves beyond synthetic nanoparticles, Codiak's focus on biological nanovesicles positions it as a leader in next-generation therapeutic delivery, with potential applications extending beyond oncology to neurodegenerative diseases, rare disorders, and vaccines.
Exosome Diagnostics
Waltham, United States
Exosome Diagnostics, founded in 2008 in Waltham, Massachusetts, emerged as a global leader in exosome-based liquid biopsy technology before being acquired by Bio-Techne Corporation. The company pioneered the use of exosomes—nanoscale extracellular vesicles (30-150 nm) naturally released by cells—as biomarkers for non-invasive disease detection and monitoring. Exosomes contain genetic material, proteins, and other molecular cargo that reflect the state of their cell of origin, making them valuable diagnostic tools for cancer and other diseases. Exosome Diagnostics developed sophisticated isolation and analysis technologies to capture these nanovesicles from bodily fluids and extract clinically relevant biomarkers, particularly RNA and DNA molecules. The company's flagship product, the ExoDx Prostate Test (IntelliScore), represents a breakthrough in prostate cancer detection, analyzing exosomal RNA from urine samples to help determine the need for prostate biopsy, thereby reducing unnecessary invasive procedures. This non-invasive approach leverages the natural biology of exosomes, which are shed into circulation and easily accessible through liquid biopsies. Exosome Diagnostics also developed comprehensive exosome isolation kits enabling researchers and clinicians to harness these nanosized vesicles for biomarker discovery and diagnostic applications. The company raised over $100 million in funding and established strategic partnerships with pharmaceutical companies and research institutions. The acquisition by Bio-Techne expanded the reach of exosome diagnostics technology within a larger life sciences organization. Exosome-based diagnostics represent a paradigm shift from traditional tissue biopsies to liquid biopsies, offering less invasive, repeatable testing that can track disease progression and treatment response. As precision medicine advances, exosome diagnostics continues to play a crucial role in enabling earlier disease detection, personalized treatment selection, and real-time monitoring, establishing exosomes as a transformative platform in nano-diagnostics and molecular medicine.
10x Genomics
Pleasanton, United States
10x Genomics, founded in 2012 in Pleasanton, California, has revolutionized biological research through innovative microfluidic and nanoscale technologies that enable unprecedented resolution in genomics analysis. The company went public on NASDAQ under ticker TXG, reflecting its status as a major player in the genomics technology sector with over 1,000 employees worldwide. 10x Genomics specializes in single-cell analysis and spatial biology, utilizing sophisticated nanofluidic systems that manipulate individual cells and molecules within nanoliter-scale droplets and nanofabricated chambers. The company's flagship Chromium platform employs microfluidic partitioning to isolate individual cells into nanoliter-sized gel beads in emulsion (GEMs), where each cell receives a unique molecular barcode. This nanotechnology-enabled approach allows researchers to analyze gene expression, immune repertoires, and epigenetic states at single-cell resolution, revealing cellular heterogeneity previously obscured in bulk tissue analysis. The Visium spatial genomics platform combines tissue imaging with transcriptomics, using nanoscale capture arrays to map gene expression while preserving spatial context within tissue sections. The newer Xenium in situ platform pushes resolution further, enabling subcellular visualization of hundreds of genes simultaneously through multiplexed in situ hybridization with nanoscale precision. These technologies rely on advanced nanofabrication techniques, precise microfluidic control, and molecular barcoding strategies that operate at nanometer scales. 10x Genomics products have become essential tools in cancer research, immunology, neuroscience, and developmental biology, enabling discoveries about cellular diversity, disease mechanisms, and therapeutic targets. The company's success demonstrates how nanotechnology enables transformative advances in life sciences, making previously impossible measurements routine. With continued innovation in nanofluidics, molecular barcoding, and imaging technologies, 10x Genomics continues to expand the frontiers of biological understanding at the single-cell and subcellular levels.
NanoLight Technologies
Pinetop, United States
NanoLight Technologies, founded in 1995 in Pinetop, Arizona, is a specialized manufacturer of advanced bioluminescent and fluorescent nanoparticle probes for biological research and imaging applications. With nearly three decades of experience, the company has become a trusted supplier of high-quality molecular imaging reagents that enable researchers to visualize biological processes at the cellular and molecular levels. NanoLight's flagship NanoLuc technology represents a breakthrough in bioluminescent reporters, offering one of the smallest and brightest bioluminescent proteins available for research applications. This engineered luciferase enzyme, when combined with its substrate coelenterazine, produces intense luminescence that enables sensitive detection of cellular events, protein interactions, and gene expression with minimal background interference. The company's coelenterazine substrates, available in multiple variants optimized for different applications, serve as essential reagents for numerous bioluminescence-based assays. These small molecule substrates are chemically synthesized to high purity standards, ensuring reliable performance in demanding research applications. NanoLight also manufactures fluorescent nanoparticle probes that leverage quantum confinement effects and surface chemistry modifications to create bright, photostable markers for cellular imaging, flow cytometry, and immunoassays. These nanoparticles, typically ranging from 10-100 nanometers in diameter, offer advantages over conventional organic dyes including enhanced brightness, resistance to photobleaching, and tunable emission wavelengths. The company's products support diverse research areas including cancer biology, neuroscience, drug discovery, and infectious disease research. As a privately-held company with 10-50 employees, NanoLight maintains close relationships with the research community, providing technical support and custom synthesis services. The company's contribution to nanotechnology lies in developing and manufacturing nanoscale imaging tools that make invisible biological processes visible, accelerating scientific discovery across life sciences disciplines.
Nanobix
Basel, Switzerland
Nanobix, founded in 2018 in Basel, Switzerland, is an innovative biotechnology company developing next-generation nanopore-based biosensors for rapid point-of-care diagnostics. Based in Basel, a global hub for pharmaceutical and biotechnology innovation, Nanobix leverages cutting-edge nanotechnology to create diagnostic devices that can detect disease biomarkers quickly and accurately outside traditional laboratory settings. The company's nanopore biosensor platform utilizes nanoscale pores—typically 1-10 nanometers in diameter—embedded in thin membranes as highly sensitive molecular detectors. When target molecules pass through or interact with these nanopores under an applied electrical field, they produce characteristic changes in ionic current that serve as molecular fingerprints for identification and quantification. This single-molecule detection approach offers exceptional sensitivity and specificity, enabling detection of biomarkers at clinically relevant concentrations from small sample volumes. Nanobix's technology addresses critical needs in point-of-care diagnostics, where rapid results can significantly impact patient management and treatment decisions. The nanopore platform is particularly well-suited for detecting nucleic acids, proteins, and other biomolecules associated with infectious diseases, cancer, and cardiovascular conditions. Unlike conventional diagnostic methods requiring extensive sample preparation and laboratory infrastructure, nanopore sensors can potentially deliver results in minutes from raw or minimally processed samples. The company has secured over $5 million in funding to advance its platform through development and validation stages. Switzerland's strong scientific ecosystem, with world-class universities and research institutions, provides Nanobix with access to expertise in nanofabrication, biosensor development, and clinical diagnostics. The company's work represents an important advancement in translating nanopore technology, originally developed for DNA sequencing, into broader diagnostic applications. As healthcare systems increasingly emphasize decentralized testing and rapid diagnosis, Nanobix's nanopore biosensors could play a significant role in bringing laboratory-quality diagnostics to point-of-care settings worldwide.
Verve Therapeutics
Boston, United States
Gene editing company using lipid nanoparticle delivery for cardiovascular disease treatment
Beam Therapeutics
Cambridge, United States
Pioneer in base editing using lipid nanoparticle delivery for precision genetic medicines
Genevant Sciences
Cambridge, United States
Developer of lipid nanoparticle and ligand conjugate delivery systems for genetic medicines
Arcturus Therapeutics
San Diego, United States
Developer of LUNAR lipid nanoparticle delivery platform for mRNA medicines
Silence Therapeutics
London, United Kingdom
Pioneer in precision RNAi medicines using mRNAi GOLD platform with GalNAc delivery
Dicerna Pharmaceuticals
Lexington, United States
Developer of GalXC RNAi platform for targeted gene silencing therapeutics
NanoCarrier
Kashiwa, Japan
Developer of micellar nanoparticle drug delivery systems for cancer treatment
Nippon Kayaku
Tokyo, Japan
Pharmaceutical and chemical company with nanomedicine portfolio including micellar formulations
Nanovex Biotechnologies
Oviedo, Spain
Biotech company developing extracellular vesicle and exosome-based delivery systems
Oxford Nanopore Technologies
Oxford, United Kingdom
Pioneer in nanopore DNA/RNA sequencing technology enabling real-time, long-read sequencing
Pacific Biosciences
Menlo Park, United States
Developer of single molecule real-time (SMRT) DNA sequencing technology
Illumina
San Diego, United States
Global leader in DNA sequencing using nanoscale flow cell technology
Nanovis
West Lafayette, United States
Developer of nanotube-reinforced polymer implants for orthopedic applications
JPK Instruments
Berlin, Germany
German AFM manufacturer specializing in life science applications
Wyatt Technology
Santa Barbara, United States
US manufacturer of light scattering instruments for nanoparticle characterization
NanoString Technologies
Seattle, United States
Developer of molecular barcoding technology for gene expression analysis
Arrowhead Pharmaceuticals
Pasadena, United States
Leader in RNAi therapeutics using targeted delivery
Crystalplex
Pittsburgh, United States
Producer of quantum dots for biomedical imaging
Nanowear
New York, United States
Developer of nanosensor-enabled smart garments for health monitoring
Nano-Bio-MEMS
Cincinnati, United States
Developer of MEMS-based nanobiosensors
Nanosphere Biosciences
Boulder, United States
Developer of nanobubble-based therapeutic delivery systems
NanoMedica
San Diego, United States
Developer of nanoparticle-based cancer therapeutics
NanoMed
Lancaster, United States
Developer of nanoscale surgical instruments
NanoTemper Technologies
Munich, Germany
Developer of microscale thermophoresis for biomolecular analysis
Translate Bio
Lexington, United States
mRNA therapeutics company with proprietary LNP technology, acquired by Sanofi
Pacific Biosciences
Menlo Park, United States
Developer of SMRT sequencing using zero-mode waveguides
Singular Genomics
La Jolla, United States
Next-gen sequencing platform with nanoscale engineering
eTheRNA Immunotherapies
Niel, Belgium
mRNA immunotherapy with proprietary delivery platform
Nutcracker Therapeutics
Emeryville, United States
Automated mRNA manufacturing with microfluidic systems
Prime Medicine
Cambridge, United States
Prime editing therapeutics with LNP delivery
Mina Therapeutics
London, United Kingdom
Small activating RNA therapeutics with LNP delivery
ReNAgade Therapeutics
Cambridge, United States
RNA delivery technology for extrahepatic targets
NanoScent
Haifa, Israel
AI-powered nano-sensor platform for scent detection
NanoEnTek
Seoul, South Korea
Lab-on-a-chip and cell analysis systems
NanoMedTrix
Berlin, Germany
Nanoparticle-based immunotherapy platform
Brooks Automation
Chelmsford, United States
Automation and cryogenic solutions for semiconductors
Novozymes
Bagsværd, Denmark
Industrial enzymes and microorganisms at nanoscale
CSIR South Africa Nano
Pretoria, South Africa
South Africa's national research council with nano center
L'Oréal Nano
Paris, France
Pioneering nanotechnology in cosmetics and skincare
Nanovetores
Florianópolis, Brazil
Nanoencapsulation technology for cosmetics
T2 Biosystems
Lexington, United States
Magnetic nanoparticle-based diagnostics
Nanoimmunotech
A Coruña, Spain
Immunomagnetic nanoparticles for diagnostics
NanoBio (BlueWillow Biologics)
Ann Arbor, United States
Nanoemulsion-based vaccines and therapeutics
Kavli Institute of Nanoscience
Delft, Netherlands
TU Delft quantum and nano research
Nanoprobes
Yaphank, United States
Gold nanoparticle conjugates for imaging
Instituto de Nanotecnologia Mexico
Mexico City, Mexico
UNAM nanotechnology research center
Ionis Pharmaceuticals
Carlsbad, United States
Antisense oligonucleotide therapeutics for genetic diseases
CRISPR Therapeutics
Zug, Switzerland
CRISPR-based gene editing therapeutics for blood disorders and cancer
Editas Medicine
Cambridge, United States
CRISPR-based medicines for genetic diseases including eye disorders
Ginkgo Bioworks
Boston, United States
Cell programming platform for bio-based products and materials
DNA Script
Paris, France
Enzymatic DNA synthesis for on-demand oligo production
Standard BioTools
South San Francisco, United States
Microfluidics and mass cytometry for life science research
Nuclera
Cambridge, United Kingdom
Desktop protein synthesis and bioprinting technology
Sphere Fluidics
Cambridge, United Kingdom
Picodroplet microfluidics for single-cell analysis and antibody discovery
Dolomite Microfluidics
Royston, United Kingdom
Microfluidic systems for droplet generation and particle synthesis
Fluigent
Paris, France
Pressure-based microfluidic flow control systems for research
Micronit
Enschede, Netherlands
Glass and silicon microfluidic chips manufacturing for life sciences
Abraxis BioScience
Los Angeles, United States
Pioneer of nanoparticle albumin-bound (nab) technology for cancer drugs
NanoBio Corporation
Ann Arbor, United States
Nanoemulsion technology for intranasal vaccines and skin treatments
Ceramisphere
Sydney, Australia
Ceramic nanoparticle drug delivery systems
Camurus
Lund, Sweden
FluidCrystal lipid-based drug delivery systems
Entos Pharmaceuticals
Edmonton, Canada
Fusogenix nucleic acid delivery platform
Arrowhead Pharmaceuticals
Pasadena, United States
TRiM RNAi therapeutics platform
Phio Pharmaceuticals
Marlborough, United States
INTASYL self-delivering RNAi technology
Nitto Denko Avecia
Milford, United States
Oligonucleotide and nucleic acid CDMO services
Ajinomoto Bio-Pharma Services
San Diego, United States
CDMO for oligonucleotides and ADCs
Daiichi Sankyo
Tokyo, Japan
Antibody-drug conjugates and nanomedicine oncology
Eisai Co.
Tokyo, Japan
Neurology and oncology with nanoformulation research
Hanmi Pharmaceutical
Seoul, South Korea
LAPSCOVERY long-acting drug delivery platform
Oncobiologics
Cranbury, United States
Biosimilar development with advanced formulation technology
Sixfold Bioscience
London, United Kingdom
AI-driven nanoparticle delivery optimization
NanoSyrinx
Sheffield, United Kingdom
Bacterial contractile injection system for protein delivery
Nuvation Bio
New York, United States
Precision oncology with targeted drug development
Leica Microsystems
Wetzlar, Germany
Optical and confocal microscopes for life science and materials
Nanyang Technological University
Singapore, Singapore
Leading research university with strong nanotechnology programs
Indian Institute of Technology Bombay
Mumbai, India
Centre for Research in Nanotechnology and Science
Nano Biotecnologia SA
São Paulo, Brazil
Nanotechnology for cosmetic and pharmaceutical applications
University of São Paulo Nanomedicine
São Paulo, Brazil
Nanomedicine research at South America's largest university
Universidad de Chile Nanoscience
Santiago, Chile
Center for Nanoscience and Nanotechnology
Pontificia Universidad Católica de Chile
Santiago, Chile
Interdisciplinary nanotechnology research
University of Waterloo Nanotechnology
Waterloo, Canada
Nanotechnology engineering program and research
Symrise
Holzminden, Germany
Fragrances, flavors, and cosmetic ingredients
Alnylam Pharmaceuticals
Cambridge, United States
Leader in RNAi therapeutics using lipid nanoparticle delivery for genetic diseases
Arbutus Biopharma
Vancouver, Canada
Develops lipid nanoparticle technology for hepatitis B and other infectious diseases
Arcturus Therapeutics
San Diego, United States
RNA medicines company using LUNAR lipid nanoparticle delivery platform
Intellia Therapeutics
Cambridge, United States
CRISPR gene editing company using lipid nanoparticle delivery for in vivo therapeutics
Editas Medicine
Cambridge, United States
Genome editing company using CRISPR with lipid nanoparticle delivery systems
Verve Therapeutics
Cambridge, United States
Gene editing company for cardiovascular disease using base editing and LNP delivery
Ionis Pharmaceuticals
Carlsbad, United States
Pioneer in antisense technology and RNA-targeted therapeutics
Arrowhead Pharmaceuticals
Pasadena, United States
RNAi therapeutics company developing targeted delivery systems for genetic medicines
Dicerna Pharmaceuticals
Lexington, United States
RNAi therapeutics using GalXC delivery platform for liver-targeted gene silencing
Exiqon
Vedbaek, Denmark
Locked nucleic acid technology for RNA research and diagnostics
Dexcom
San Diego, United States
Continuous glucose monitoring using advanced nanosensor technology
Senseonics
Germantown, United States
Implantable continuous glucose monitoring with fluorescent nanosensor technology
Smith+Nephew
Watford, United Kingdom
Medical devices with nanocrystalline silver wound care and orthopedic implants
Edwards Lifesciences
Irvine, United States
Heart valve technologies with nano-engineered surfaces and coatings
Selecta Biosciences
Watertown, United States
ImmTOR biodegradable nanoparticles for immune tolerance induction
Halozyme Therapeutics
San Diego, United States
ENHANZE technology enabling subcutaneous delivery of biologics
Lipocine
Salt Lake City, United States
Lipid-based oral drug delivery platform for poorly bioavailable compounds
Novavax
Gaithersburg, United States
Recombinant nanoparticle vaccine technology for infectious diseases
Vaxart
South San Francisco, United States
Oral vaccine platform using recombinant vectors and nanoparticle technology
Afrigen Biologics
Cape Town, South Africa
African mRNA vaccine hub developing lipid nanoparticle delivery technology
Serum Institute of India
Pune, India
World's largest vaccine manufacturer exploring nanoparticle vaccine technology
SK Bioscience
Seongnam, South Korea
Vaccine and biopharmaceutical company with nanoparticle vaccine capabilities
Quotient Sciences
Nottingham, United Kingdom
Drug development services including nanoparticle formulation technologies
Hovione
Loures, Portugal
CDMO with spray-dried nanoparticle and amorphous dispersion technologies
Cambrex
East Rutherford, United States
Contract manufacturer with particle engineering and nanoformulation capabilities
Siegfried Holding
Zofingen, Switzerland
Pharmaceutical CDMO with particle engineering and formulation capabilities
Polymun Scientific
Klosterneuburg, Austria
CDMO specializing in liposomal and lipid nanoparticle formulations
Lipoid GmbH
Ludwigshafen, Germany
Manufacturer of high-purity phospholipids for drug delivery and diagnostics
BioVision
Milpitas, United States
Life science reagents including nanoparticle-based assays and detection kits
Cytodiagnostics
Burlington, Canada
Gold nanoparticles and conjugates for lateral flow and diagnostic applications
Ocean NanoTech
San Diego, United States
Quantum dots, iron oxide, and magnetic nanoparticles for biomedical research
Spherotech
Lake Forest, United States
Microspheres and nanoparticles for flow cytometry, diagnostics, and research
Bangs Laboratories
Fishers, United States
Microspheres and polymer beads for diagnostics and flow cytometry
Miltenyi Biotec
Bergisch Gladbach, Germany
Magnetic cell separation using superparamagnetic nanoparticles
STEMCELL Technologies
Vancouver, Canada
Cell separation and culture products using magnetic nanoparticle technology
Akadeum Life Sciences
Ann Arbor, United States
Microbubble technology for fast, gentle cell separation and enrichment
Bio-Techne
Minneapolis, United States
Life science tools including nanoparticle-based reagents and spatial biology
bioMérieux
Marcy-l'Étoile, France
In vitro diagnostics with nanoparticle-based detection technologies
Hologic
Marlborough, United States
Molecular diagnostics with advanced detection technologies for women's health
Guardant Health
Redwood City, United States
Liquid biopsy for cancer detection using circulating tumor DNA analysis
GRAIL
Menlo Park, United States
Multi-cancer early detection using cell-free DNA and advanced sequencing
Foundation Medicine
Cambridge, United States
Comprehensive genomic profiling for cancer using advanced sequencing
Tempus
Chicago, United States
AI-driven precision medicine with genomic sequencing and diagnostics
Natera
Austin, United States
Cell-free DNA testing for prenatal screening and cancer detection
Invitae
San Francisco, United States
Genetic testing company with comprehensive hereditary cancer panels
Myriad Genetics
Salt Lake City, United States
Molecular diagnostics for hereditary cancer and prenatal screening
Color Health
Burlingame, United States
Population-scale genetic testing and COVID-19 testing infrastructure
23andMe
Sunnyvale, United States
Consumer genetics company with health and ancestry DNA testing
Ancestry
Lehi, United States
Family history and consumer DNA testing using advanced genotyping
BGI Genomics
Shenzhen, China
Genomics company with sequencing platforms and diagnostic services
Berry Genomics
Beijing, China
Non-invasive prenatal testing and genetic diagnostics in China
Annoroad Gene Technology
Beijing, China
Genomic sequencing services and bioinformatics solutions
Burning Rock Biotech
Guangzhou, China
Cancer genomics and liquid biopsy diagnostics company in China
Singlera Genomics
Shanghai, China
DNA methylation-based early cancer detection and liquid biopsy
MGI Tech
Shenzhen, China
DNA sequencing instruments and reagents using proprietary technology
Merck Millipore
Darmstadt, Germany
Lab filtration and bioprocessing with nanopore membrane technology
Sartorius
Göttingen, Germany
Bioprocess and lab equipment with nanofiltration and membrane technology
Agency for Science, Technology and Research
Singapore, Singapore
Singapore research agency with multiple nanotechnology-focused institutes
Vietnam National University Nanotechnology
Hanoi, Vietnam
Leading Vietnamese university with nanotechnology research programs
Council of Scientific and Industrial Research
New Delhi, India
Indian network of research labs with extensive nanotechnology programs
National Chemical Laboratory
Pune, India
CSIR laboratory specializing in catalysis and nanotechnology research
South African Nanotechnology Initiative
Pretoria, South Africa
National initiative coordinating nanotechnology research in South Africa
Zewail City of Science and Technology
Giza, Egypt
Science city with nanoscience and nanotechnology research centers
Instituto Potosino de Investigación Científica y Tecnológica
San Luis Potosí, Mexico
Mexican research institute with advanced materials and nanotechnology
Universidade de São Paulo Nano
São Paulo, Brazil
Leading Brazilian university with extensive nanotechnology research
UNICAMP Nanotechnology
Campinas, Brazil
Brazilian university with semiconductor and nanotechnology facilities
Centro de Investigaciones en Bionanociencias
Buenos Aires, Argentina
Argentine center for bio-nanoscience and advanced imaging
Weizmann Institute of Science
Rehovot, Israel
World-class research institute with pioneering nanoscience programs
Hebrew University of Jerusalem Nano
Jerusalem, Israel
Major Israeli university with Center for Nanoscience and Nanotechnology
Chinese University of Hong Kong
Hong Kong, Hong Kong
Major university with Institute of NanoMaterials and NanoTechnology
Fudan University Nano
Shanghai, China
Top Shanghai university with nanotechnology research centers
Kyoto University Nano
Kyoto, Japan
Leading Japanese university with iCeMS nanobio research
Osaka University Nano
Osaka, Japan
Major Japanese university with SANKEN nanotechnology research
Seoul National University Nano
Seoul, South Korea
Korea's top university with Institute for Basic Science nanotech
Fraunhofer Society Nano
Munich, Germany
German applied research network with nanotechnology institutes
NanoEnTek
Seoul, South Korea
Microfluidics and nano-scale diagnostic devices for life sciences
JPK Instruments (Bruker)
Berlin, Germany
Bio-AFM systems for life sciences, now part of Bruker
Twist Bioscience
South San Francisco, United States
Silicon-based DNA synthesis platform for synthetic biology
Nautilus Biotechnology
Seattle, United States
Single-molecule proteomics platform for comprehensive protein analysis
Element Biosciences
San Diego, United States
Benchtop DNA sequencing with accuracy at scale
Ultima Genomics
Newark, United States
Ultra-low-cost genome sequencing technology
NanoCellect Biomedical
San Diego, United States
Microfluidic cell sorting for single-cell applications
Refeyn
Oxford, United Kingdom
Mass photometry for label-free protein characterization
Dolomite Microfluidics
Royston, United Kingdom
Microfluidic systems for droplet generation and particle synthesis
RainDance Technologies (Bio-Rad)
Billerica, United States
Droplet digital PCR technology, acquired by Bio-Rad
Sophion Bioscience
Copenhagen, Denmark
Automated patch clamp systems for ion channel research
Nanion Technologies
Munich, Germany
Automated patch clamp and ion channel research tools
Alnylam Pharmaceuticals
Cambridge, United States
Pioneer in RNAi therapeutics with lipid nanoparticle delivery
Denali Therapeutics
South San Francisco, United States
Neurodegeneration drugs using Transport Vehicle BBB-crossing technology
Passage Bio
Philadelphia, United States
AAV gene therapies for CNS diseases with novel delivery
Voyager Therapeutics
Cambridge, United States
AAV capsid engineering for CNS gene therapy delivery
Spark Therapeutics
Philadelphia, United States
Gene therapy pioneer (Luxturna) now part of Roche
Bluebird Bio
Somerville, United States
Gene therapy using lentiviral vectors for genetic diseases
LogicBio Therapeutics
Lexington, United States
Gene insertion technology using AAV and GeneRide platform
Generation Bio
Cambridge, United States
Non-viral gene therapy using lipid nanoparticle delivery
Stoke Therapeutics
Bedford, United States
Antisense oligonucleotides to upregulate protein expression
Entos Pharmaceuticals
Edmonton, Canada
Fusogenix DNA delivery platform for gene therapy
Replicate Bioscience
San Diego, United States
Self-replicating RNA therapeutics platform
Chimeron Bio
Philadelphia, United States
Chimeric viral vectors for improved gene therapy delivery
Entrada Therapeutics
Boston, United States
Endosomal Escape Vehicle (EEV) platform for intracellular delivery
Bicycle Therapeutics
Cambridge, United Kingdom
Bicyclic peptide platform for targeted drug delivery
PeptiDream
Kawasaki, Japan
Peptide Drug Discovery Platform System for macrocyclic therapeutics
Sorrento Therapeutics
San Diego, United States
Biopharmaceutical with ADC and nanoparticle delivery platforms
Mersana Therapeutics
Cambridge, United States
Antibody drug conjugates using Dolasynthen platform
ADC Therapeutics
Lausanne, Switzerland
Antibody drug conjugates for hematological malignancies
Seagen
Bothell, United States
ADC pioneer (Adcetris, Padcev) acquired by Pfizer
ImmunoGen
Waltham, United States
ADC technology company acquired by AbbVie
Synaffix
Amsterdam, Netherlands
ADC technology platform using GlycoConnect and toxSYN
Abzena
Cambridge, United Kingdom
ADC development and manufacturing CDMO
Sutro Biopharma
South San Francisco, United States
Cell-free protein synthesis for site-specific ADC conjugation
Bioasis Technologies
Guilford, Canada
xB3 platform for blood-brain barrier crossing drug delivery
AngioChem
Montreal, Canada
Peptide-drug conjugates for CNS delivery across BBB
Annexon Biosciences
Brisbane, United States
Complement cascade inhibitors for neurological diseases
Prevail Therapeutics
New York, United States
Gene therapies for neurodegenerative diseases (Eli Lilly)
Sangamo Therapeutics
Brisbane, United States
Zinc finger nuclease gene editing and gene regulation
Applied Genetic Technologies
Alachua, United States
AAV gene therapies for rare ophthalmologic diseases
Regenxbio
Rockville, United States
AAV gene therapy using NAV Technology Platform
MeiraGTx
New York, United States
Gene therapy for inherited retinal diseases and beyond
Krystal Biotech
Pittsburgh, United States
Gene therapies using HSV-1 vectors for skin diseases
Sarepta Therapeutics
Cambridge, United States
Gene therapy and RNA therapeutics for muscular dystrophies
Solid Biosciences
Charlestown, United States
Gene therapy for Duchenne muscular dystrophy
Ultragenyx Pharmaceutical
Novato, United States
Gene therapy and biologics for rare genetic diseases
Rocket Pharmaceuticals
Cranbury, United States
Lentiviral and AAV gene therapies for rare diseases
Genethon
Evry, France
Non-profit gene therapy research laboratory
Lysogene
Paris, France
CNS-targeted gene therapy for lysosomal storage diseases
Freeline Therapeutics
Stevenage, United Kingdom
AAV gene therapy for liver-targeted diseases
Orchard Therapeutics
London, United Kingdom
Hematopoietic stem cell gene therapy for rare diseases
Synthego
Redwood City, United States
CRISPR reagent supplier and genome engineering platform
Mammoth Biosciences
Brisbane, United States
CRISPR diagnostics and therapeutics using novel Cas proteins
Poseida Therapeutics
San Diego, United States
Gene editing and CAR-T cell therapy using piggyBac system
Precision BioSciences
Durham, United States
ARCUS genome editing for cell therapy and gene correction
Cellectis
Paris, France
TALEN gene editing for allogeneic CAR-T cell therapy
Carisma Therapeutics
Philadelphia, United States
CAR-Macrophage therapy for solid tumors
Fate Therapeutics
San Diego, United States
iPSC-derived cell therapies including NK and T cells
Materialise
Leuven, Belgium
3D printing software and services pioneer with medical, industrial and consumer applications
BICO Group (Cellink)
Gothenburg, Sweden
Life science technology with bioprinting and bioinks for tissue engineering and drug discovery
Organovo
San Diego, United States
3D bioprinting pioneer developing human tissues for drug discovery and therapeutic applications
Aspect Biosystems
Vancouver, Canada
Microfluidic bioprinting for tissue therapeutics and drug delivery applications
Prellis Biologics
San Francisco, United States
Holographic bioprinting for vascularized tissues and organs at high speed and resolution
Photocentric
Peterborough, United Kingdom
LCD-based resin 3D printing for mass manufacturing with large build volumes
Intuitive Surgical
Sunnyvale, United States
Pioneer in robotic-assisted minimally invasive surgery with da Vinci systems
Stryker Robotics
Kalamazoo, United States
Medical technology company with Mako robotic-arm assisted surgery system
Medtronic Surgical Robotics
Dublin, Ireland
Global medical device leader with Hugo robotic-assisted surgery platform
Rewalk Robotics
Yokneam, Israel
Wearable robotic exoskeletons enabling individuals with spinal cord injury to walk
Ekso Bionics
Richmond, United States
Exoskeleton technology for medical rehabilitation and industrial applications
Ultragenyx Pharmaceutical
Novato, United States
Biopharmaceutical company developing novel products for rare and ultra-rare diseases
Biomarin Pharmaceutical
San Rafael, United States
Global biotechnology company developing therapies for rare genetic diseases
Vertex Pharmaceuticals
Boston, United States
Global biotechnology company focused on cystic fibrosis and gene editing therapies
Kite Pharma
Santa Monica, United States
Cell therapy company developing engineered autologous CAR T-cell cancer immunotherapies
Bristol Myers Squibb Cell Therapy
Summit, United States
Global biopharmaceutical company with leading CAR T cell therapy franchise
Allogene Therapeutics
South San Francisco, United States
Clinical-stage biotechnology company pioneering allogeneic CAR T cell therapies
Caribou Biosciences
Berkeley, United States
Clinical-stage CRISPR genome editing company developing transformative therapies
Lyell Immunopharma
South San Francisco, United States
T cell reprogramming company developing next-generation cell therapies for solid tumors
Adicet Bio
Menlo Park, United States
Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies
Century Therapeutics
Philadelphia, United States
Biotechnology company developing iPSC-derived allogeneic cell therapies for cancer
Takeda Cell Therapy
Tokyo, Japan
Global pharmaceutical company with advanced cell therapy programs
Daiichi Sankyo ADC
Tokyo, Japan
Global pharmaceutical company with leading ADC technology platform
Berkeley Lights
Emeryville, United States
Digital cell biology company using optoelectronic positioning for single cell manipulation
Codexis
Redwood City, United States
Enzyme engineering company developing biocatalysts for pharmaceutical manufacturing
Absci
Vancouver, United States
Generative AI drug creation company designing and validating novel biologic drugs
Evonetix
Cambridge, United Kingdom
DNA synthesis company using semiconductor technology for desktop DNA writing
Molecular Assemblies
San Diego, United States
Enzymatic DNA synthesis company enabling rapid gene synthesis and DNA data storage
Catalog Technologies
Boston, United States
DNA data storage company developing massive-scale digital data storage in DNA
Resilience
San Diego, United States
Biomanufacturing company building sustainable network for complex medicine production
Charles River Cell Solutions
Wilmington, United States
Contract research organization providing cell and gene therapy development services
WuXi Advanced Therapies
Shanghai, China
Global contract development and manufacturing organization for advanced therapies
Rocket Pharmaceuticals
Cranbury, United States
Gene therapy company developing treatments for rare childhood diseases
Abeona Therapeutics
New York, United States
Clinical-stage biopharmaceutical company developing gene therapies for rare diseases
LogicBio Therapeutics
Lexington, United States
Genome editing company developing gene insertion medicines for pediatric diseases
Lexeo Therapeutics
New York, United States
Gene therapy company developing treatments for cardiac and neurological diseases
Neurogene
New York, United States
Gene therapy company developing treatments for rare neurological diseases in children
Sana Biotechnology
Seattle, United States
Biotechnology company engineering cells to treat disease using in vivo and ex vivo approaches
Taysha Gene Therapies
Dallas, United States
Gene therapy company developing treatments for monogenic CNS diseases
Varian Medical Systems
Palo Alto, United States
Medical device company focused on radiation oncology treatments
Fresenius Medical Care
Bad Homburg, Germany
World's leading provider of products and services for dialysis patients
Nevro
Redwood City, United States
Medical device company developing high-frequency spinal cord stimulation therapy
NeuroPace
Mountain View, United States
Medical device company developing responsive neurostimulation for epilepsy
Resmed
San Diego, United States
Medical device company developing products for sleep apnea and respiratory care
iRhythm Technologies
San Francisco, United States
Digital healthcare company providing ambulatory cardiac monitoring services
Inspire Medical Systems
Maple Grove, United States
Medical technology company developing implantable neurostimulation for sleep apnea
TransMedics
Andover, United States
Medical technology company developing organ care system for transplantation
Qiagen
Hilden, Germany
Provider of sample to insight solutions for molecular diagnostics
Veracyte
South San Francisco, United States
Genomic diagnostics company improving cancer diagnosis and treatment
CareDx
Brisbane, United States
Precision medicine company focused on transplant diagnostics
Adaptive Biotechnologies
Seattle, United States
Biotechnology company developing immune-driven medicine through sequencing
Senseonics Holdings
Germantown, United States
Medical technology company developing implantable continuous glucose monitoring
Globus Medical
Audubon, United States
Medical device company developing musculoskeletal solutions and robotics
Integra LifeSciences
Princeton, United States
Global medical technology company focused on regenerative technologies
Haemonetics
Boston, United States
Global healthcare company providing blood management solutions
Integer Holdings
Frisco, United States
Medical device outsource manufacturer providing batteries and components
Vicarious Surgical
Waltham, United States
Robotics company developing next-gen surgical robots with human-like movement
Procept BioRobotics
Redwood City, United States
Surgical robotics company developing Aquablation therapy for BPH
Asensus Surgical
Durham, United States
Medical device company developing digitized laparoscopic surgical systems
CMR Surgical
Cambridge, United Kingdom
Surgical robotics company developing the Versius surgical system
Distalmotion
Lausanne, Switzerland
Medical robotics company developing the Dexter robotic surgical system
Carbios
Clermont-Ferrand, France
Biotech company developing enzymatic solutions for plastic and textile recycling
Weights & Biases
San Francisco, United States
ML platform for experiment tracking, model management, and MLOps
Beyond Meat
El Segundo, United States
Plant-based meat company with products designed to replicate animal protein
BlueNalu
San Diego, United States
Cultivated seafood company producing cell-based fish products
Wildtype
San Francisco, United States
Cultivated salmon company growing sushi-grade salmon from cells
Perfect Day
Berkeley, United States
Precision fermentation company producing animal-free dairy proteins
New Culture
San Francisco, United States
Precision fermentation company producing animal-free mozzarella cheese
Clara Foods
San Francisco, United States
Precision fermentation company producing animal-free egg proteins
Motif FoodWorks
Boston, United States
Food ingredient company using biotech to create meat and dairy alternatives
Ripple Foods
Emeryville, United States
Pea protein milk company providing sustainable dairy alternatives
Indigo Agriculture
Boston, United States
Agricultural technology company using plant microbiome for crop improvement
Pivot Bio
Berkeley, United States
Microbial nitrogen company providing biological nitrogen fixation for crops
Ginkgo Bioworks Agriculture
Boston, United States
Ginkgo Bioworks agriculture division engineering microbes for farming
Benson Hill
St. Louis, United States
Food tech company using CropOS platform to develop better plant genetics
Pairwise
Durham, United States
Gene editing company developing better fruits and vegetables using CRISPR
Inari Agriculture
Cambridge, United States
Seed design company using gene editing for sustainable crop improvement
ADM
Chicago, United States
Global food processing and ingredients company with alternative protein investments
Sensoria
Redmond, United States
Smart textile company developing sensor-embedded garments for fitness and health
Hexoskin
Montreal, Canada
Smart clothing company with biometric monitoring for health and performance
Fitbit
San Francisco, United States
Fitness wearables company acquired by Google for health tracking devices
Nexon
Tokyo, Japan
Japanese-Korean game company pioneering free-to-play games
Therabody
Los Angeles, United States
Wellness technology company known for Theragun percussion devices
Kitman Labs
Dublin, Ireland
Sports science and injury prevention analytics platform
Zone7
San Francisco, United States
AI-powered injury prediction and prevention platform
Mindbody
San Luis Obispo, United States
Business management software for fitness and wellness
MyFitnessPal
Baltimore, United States
Nutrition tracking and fitness app with food database
Noom
New York, United States
Behavior change platform for weight loss and health
Meati Foods
Boulder, United States
Mycelium-based meat alternative company
Motif FoodWorks
Boston, United States
Food ingredient company improving plant-based products
Indigo Agriculture
Boston, United States
Agricultural technology company using microbiology and carbon credits
Prospera Technologies
Tel Aviv, Israel
AI and computer vision for agriculture
Arable
Princeton, United States
Agricultural sensing and analytics platform
CropX
Tel Aviv, Israel
Soil sensing and irrigation management platform
Granular
San Francisco, United States
Farm management software platform
InnovaFeed
Paris, France
Insect protein producer for aquaculture and pet food
Revinate
San Francisco, United States
Hotel CRM and direct booking platform
Sterling
New York, United States
Background and identity verification services for global hiring
Bright Health
Minneapolis, United States
Health insurance company partnering with care delivery systems
Devoted Health
Waltham, United States
Medicare Advantage plans with technology-driven care model
Embroker
San Francisco, United States
Digital commercial insurance broker for businesses and startups
Alan
Paris, France
Digital health insurance company in Europe
D2L Brightspace
Kitchener, Canada
Cloud-based learning platform with personalized learning paths
Skillshare
New York, United States
Online learning community for creative and professional skills
Khan Academy
Mountain View, United States
Free online education platform offering courses for all ages
Labster
Copenhagen, Denmark
Virtual science lab simulations for higher education
Chegg
Santa Clara, United States
Student-first connected learning platform with study tools
Kahoot!
Oslo, Norway
Game-based learning platform for engaging quizzes and presentations
Nearpod
Fort Lauderdale, United States
Interactive lesson platform for K-12 student engagement
ExamSoft
Dallas, United States
Digital assessment platform with secure exam delivery
Renaissance Learning
Bloomington, United States
K-12 assessment and learning analytics platform
Age of Learning
Glendale, United States
Digital education programs for children from birth through sixth grade
Scribd
San Francisco, United States
Digital reading subscription service for books and documents
TrainHeroic
Denver, United States
Strength and conditioning platform for coaches and athletes
Meati Foods
Boulder, United States
Mushroom root mycelium company creating whole-cut meat alternatives
Alan
Paris, France
Digital health insurance in Europe
Granular
San Francisco, United States
Farm management software platform
Prospera Technologies
Tel Aviv, Israel
AI-powered crop monitoring and analytics
Trace Genomics
San Francisco, United States
Soil microbiome testing and analytics
Biome Makers
West Sacramento, United States
Soil and plant microbiome intelligence
Joyn Bio
Boston, United States
Engineered microbes for nitrogen fixation
Kula Bio
Somerville, United States
Biological nitrogen for sustainable farming
Harvest CROO Robotics
Tampa, United States
Robotic strawberry harvester
Slate
San Francisco, United States
Baseball player development platform
Endel
Berlin, Germany
AI-powered soundscapes for wellness
Wyzant
Chicago, United States
Online tutoring marketplace
Course Hero
Redwood City, United States
Study resources and tutoring
Outschool
San Francisco, United States
Live online classes marketplace
Numerade
Los Angeles, United States
STEM video learning platform
Handshake
San Francisco, United States
College career network
BetterUp
San Francisco, United States
Coaching and mental fitness platform
Glint
Sunnyvale, United States
Employee engagement platform
BIMA
Stockholm, Sweden
Mobile insurance for emerging markets
Nava PBC
Washington, United States
Public benefit corporation for government technology
Agrinos
Davis, United States
Biological crop inputs
Gym Pass
New York, United States
Corporate fitness and wellness platform
SubmitHub
Los Angeles, United States
Music submission platform
JustAnswer
San Francisco, United States
JustAnswer is an online platform connecting users with verified experts across multiple fields including legal, medical, veterinary, technical support, and automotive, providing on-demand answers and consultations for everyday questions and problems. Founded in 2003 in San Francisco with over $100 million in funding and 500+ employees, JustAnswer has facilitated millions of expert consultations, serving users in over 196 countries. The platform employs thousands of credentialed professionals including lawyers, doctors, veterinarians, mechanics, and technicians who provide personalized answers to user questions through a pay-per-question or subscription model. JustAnswer's legal category connects users with licensed attorneys who can provide guidance on family law, contracts, estate planning, employment disputes, and other legal matters at a fraction of traditional consultation costs. The medical experts offer health advice, symptom assessment, and second opinions, though they appropriately direct users to emergency services for urgent situations. Veterinary professionals help pet owners with animal health concerns, behavior issues, and treatment options. The platform's technical support experts assist with computer problems, software issues, and consumer electronics troubleshooting. JustAnswer's question-and-answer format allows users to describe their situation in detail, upload photos or documents, and engage in back-and-forth conversation until their question is fully answered. The platform verifies expert credentials, tracks customer satisfaction ratings, and maintains quality standards through monitoring and feedback systems. Users can browse previously answered questions, benefiting from the knowledge base built by millions of interactions. With 24/7 availability, multilingual support, and expertise across dozens of specialties, JustAnswer provides accessible, affordable expert guidance for everyday problems that might otherwise require expensive professional consultations.
Izon Science
Christchurch, New Zealand
Tunable resistive pulse sensing
Nanotope
Evanston, United States
Self-assembling peptide nanomaterials
Ademtech
Pessac, France
Superparamagnetic beads for diagnostics
Elveflow
Paris, France
Microfluidic instruments for nanoparticle synthesis
Nanopass Technologies
Ness Ziona, Israel
Microneedle technology for intradermal drug delivery
Schrödinger
New York, United States
Molecular simulation software for drug discovery and materials
Accelrys (BIOVIA)
San Diego, United States
Materials Studio simulation software for nanomaterials
INBRAIN Neuroelectronics
Barcelona, Spain
Advanced neural interfaces from graphene for therapeutic brain-computer applications
ARIZ Precision Medicine
San Diego, United States
Nanotechnology for targeted cancer drug delivery using siRNA nanoparticles
SeraGene Therapeutics
London, United Kingdom
RNA and nanomedicine treatments for blood disorders
Nanoligent
Leuven, Belgium
Oncology nanodrug development
Madrigal Mental Care
Boston, United States
Organic nanoparticle drug delivery for mental health
BioPrime AgriSolutions
Pune, India
Nanotechnology solutions for agriculture
Theranautilus
Bangalore, India
Nanobots for dental healthcare and root canal disinfection
Cellino
Cambridge, United States
AI-guided laser platform for personalized cell therapy manufacturing
Helex
Boston, United States
Lipid nanoparticle technology for targeted drug delivery for kidney diseases
Bio-Gate
Nuremberg, Germany
Silver nanotechnology for antimicrobial medical products and consumer goods
DNA Nanobots
Cambridge, United States
DNA-based nanodevices for targeted therapeutics delivery, vaccines, and diagnostics
Avisi Technologies
San Diego, United States
VisiPlate nanotechnology-enabled ocular implant for glaucoma treatment
BioPact
Delft, Netherlands
Nanoformulation technology for drug delivery applications
Bionano Genomics
San Diego, United States
Genome analysis tools using nanochannel technology
UPM Biomedicals
Helsinki, Finland
Nanofibrillar cellulose for drug screening, personalized medicine, and tissue engineering
Nanollose
Perth, Australia
Tree-free nanocellulose fibers from waste for sustainable textiles
CelluComp
Fife, United Kingdom
Cellulose nanofiber from root vegetables for composite applications
Poly-Dtech
Strasbourg, France
Fluorescent nanoparticle-based immunoassays and lateral flow tests for biomarker detection
Envue Technologies
Stockholm, Sweden
Nanofluidic scattering microscopy for protein and biomolecule characterization
Nostics
Amsterdam, Netherlands
AI-powered nanotechnology diagnostics for fast and accurate disease detection
Sona Nanotech
Halifax, Canada
Non-toxic gold nanorods for photothermal therapy and tumor-targeting drug delivery
Adocia
Lyon, France
BioChaperone nanoformulation technology for improved insulin delivery
Natural Immunogenics
Sarasota, United States
Colloidal silver nanoparticle products for antimicrobial applications
Silversol
Salt Lake City, United States
Silver nanoparticle technology for wound care and antimicrobial applications
Nanocare
Mumbai, India
Silver nanoparticle antimicrobial coatings for textiles and medical applications
Nano-Yield
Kansas City, United States
Patented nanotechnology for crop enhancement and precision agriculture
Tandem Nano
Boston, United States
Nanoformulation delivery solutions for agriculture and pharmaceuticals
NanoVeda
Mumbai, India
Nanotechnology-based wellness and skincare products
UpNano
Vienna, Austria
High-speed two-photon 3D printing for microoptics and biomedical applications
NanoBioTech Turkey
Istanbul, Turkey
Plant-based antimicrobial nanoparticles from silver, zinc, and iron
Ceramat
Chennai, India
Nano-hydroxyapatite ceramic implant coatings and bone grafting materials
Promimic
Gothenburg, Sweden
HAnano Surface hydroxyapatite coating for dental and orthopedic implants
SofSera
Tokyo, Japan
Hydroxyapatite nanoparticles for dental and biomedical applications
Diagnostic anSERS
College Park, United States
Handheld SERS-based detector for drugs and explosives identification
Aruna Bio
Athens, United States
Neural-derived exosomes for CNS drug delivery crossing BBB
BioMagnetic Solutions
State College, United States
Magnetic nanoparticle solutions for bioseparation and diagnostics
Micromod Partikeltechnologie
Rostock, Germany
Magnetic micro and nanoparticles for life science applications
Nanordica Medical
Tartu, Estonia
Silver and copper nanoparticle wound care products
ConvaTec Aquacel
Reading, United Kingdom
Aquacel silver-based wound care technology